Home - Products - Others - Other Targets - 3beta-Methoxy-2,3-dihydro-4,7-didehydrophysalin B

3beta-Methoxy-2,3-dihydro-4,7-didehydrophysalin B

CAS No. 1173241-82-1

3beta-Methoxy-2,3-dihydro-4,7-didehydrophysalin B( ——— )

Catalog No. M39283 CAS No. 1173241-82-1

3beta-Methoxy-2,3-dihydro-4,7-didehydrophysalin B

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 811 In Stock
25MG Get Quote In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    3beta-Methoxy-2,3-dihydro-4,7-didehydrophysalin B
  • Note
    Research use only, not for human use.
  • Brief Description
    3beta-Methoxy-2,3-dihydro-4,7-didehydrophysalin B
  • Description
    3beta-Methoxy-2,3-dihydro-4,7-didehydrophysalin B
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    1173241-82-1
  • Formula Weight
    540.6
  • Molecular Formula
    C29H32O10
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Myosin Kinase Inhibi...

    Myosin light chain kinase fragment 11-19 amide (MLCK(11-19) amide) is a substrate-specific peptide inhibitor of MLCK. Myosin light chain kinase fragment 11-19 amide inhibits hypotonicity-induced Ca2+ entry. Myosin light chain kinase fragment 11-19 amide can be used in the research of human cervical cancer.

  • Mc-Val-Ala-PAB

    Mc-Val-Ala-PAB, an effective linker, is utilized in antibody-drug-conjugate (ADC).

  • Antiproliferative ag...

    Antiproliferative agent-16 (Antiproliferative agent-16) is an indolyl hydrazide-hydrazone compound with anticancer activity. Antiproliferative agent-16 exhibits specificity toward breast cancer cells (IC50 of 6.94 μM for MCF-7 cells).